Research

Hormonal

GLP-1 receptor agonists improve metabolic outcomes, including glycemic control, blood pressure, and lipid profiles, in post-bariatric surgery patients.

Beyond weight loss, GLP-1 agonists can help normalize blood sugar, lower blood pressure, and improve cholesterol levels in patients who have had bariatric surgery. This makes them a valuable tool for managing overall metabolic health, not just weight.

ModerateSupportsMEDIUM confidence
A systematic review of 6 studies on the metabolic effects of GLP-1 receptor agonists (RA) post-bariatric surgery highlighted significant improvements in glycemic control, blood pressure, cholesterol levels, and liver function.
Yee Wen Tan et al. · Langenbeck s Archives of Surgery · 2025

Why this rating

Based on a systematic review of 6 studies, but meta-analysis was not feasible due to heterogeneity.

Source

GLP-1 receptor agonists as an adjunct to bariatric surgery for weight loss and metabolic outcome improvement: a systematic review and meta-analysis

Yee Wen Tan et al. · Langenbeck s Archives of Surgery · 2025

DOI 10.1007/s00423-025-03831-4

Meta-analysis · 19 studiesCited 9×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →